中华人民共和国疫苗管理法（征求意见稿）(96)
<P style="LINE-HEIGHT: 150%; TEXT-INDENT: 32pt; MARGIN: 0cm 0cm 0pt; mso-char-indent-count: 2.0" class=MsoNormal><FONT face="Times New Roman"><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（六）严惩重处违法行为。</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">坚决落实“四个最严”，综合运用民事责任、刑事责任、行政责任手段，强化疫苗上市许可持有人和相关主体责任。明知疫苗存在质量问题仍然销售的，受种者可以要求惩罚性赔偿</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（第八十四条）</SPAN></FONT><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'">。</SPAN><FONT face="Times New Roman"><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">相关违法行为构成犯罪的，依法追究刑事责任</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（第八十六条）</SPAN></FONT><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'">。</SPAN><FONT face="Times New Roman"><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">行政责任方面，对违反疫苗管理规定的，处罚幅度总体在《药品管理法》处罚幅度内从重</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（第八十六条）</SPAN></FONT><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'">。</SPAN><FONT face="Times New Roman"><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">总结近年来疫苗案件暴露的问题，对数据造假等主观故意违法行为予以严惩</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（第八十九条）</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">。落实</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 16pt; mso-fareast-font-family: 仿宋_GB2312" lang=EN-US>“</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">处罚到人</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 16pt; mso-fareast-font-family: 仿宋_GB2312" lang=EN-US>”</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">要求，上市许可持有人有严重违法行为的，对法定代表人、主要负责人和其他关键岗位人员，<SPAN style="COLOR: black">没收在违法期间自本单位所获收入，并处以百分之五十以上、一倍以下罚款</SPAN>，十年内不得从事药品生产经营活动；情节特别严重的，终身不得从事药品生产经营活动</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（第八十八条、第八十九条）</SPAN></FONT><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'">。</SPAN><FONT face="Times New Roman"><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">强化监管部门和地方政府责任追究。<SPAN style="COLOR: black">监管部门不履行或者不正确履行职责、造成严重后果的，地方政府组织领导不力造成严重损害的，依法严肃追究责任。参与、包庇、纵容疫苗违法犯罪行为，弄虚作假、隐瞒事实、干扰阻碍责任调查，或者帮助伪造、隐匿、销毁证据的，依法从重追究责任</SPAN></SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（第九十六条、第九十七条）</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; COLOR: black; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">。</SPAN><SPAN style="LINE-HEIGHT: 150%; COLOR: black; FONT-SIZE: 16pt; mso-fareast-font-family: 仿宋_GB2312" lang=EN-US><o:p></SPAN></FONT></P>


总共97页  [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] 96 [97] 
上一页  下一页